WCRX : Analysis & Opinions

  1. Pharma & Biotech Stock Outlook - July/Aug 2013 - Industry Outlook

    July 30, 2013
    Pharma & Biotech Stock Outlook - July/Aug 2013 - Industry Outlook
  2. Actavis Files Patent Infringement Lawsuit - Analyst Blog

    June 21, 2013
    Sandoz and Hetero are looking to launch their generic versions of Actavis/Kissei's Rapaflo.
  3. Actavis-Medicines360 Ink Partnership - Analyst Blog

    June 13, 2013
    Actavis gained commercial rights in the US and Canada to the LNG20 intrauterine device.
  4. A Good Deal For Actavis, But Warner Chilcott Goes A Little Cheap

    May 21, 2013
    Actavis gets a very useful asset, while Warner Chilcott shareholders get a decent exit.
  5. Endo Health Solutions Needs Some Solutions Of Its Own

    November 7, 2012
    Can Endo reestablish itself as a quality healthcare name?
  6. Randgold Resources Ltd Among the Nasdaq's Biggest Movers on September ...

    September 6, 2012
    This morning has been good for the market. The Nasdaq is trading up 1.9%; the S&P 500 is up 1.8%; and the Dow has climbed ...
  7. Big Movers on the Healthcare Sector Today, Including ESRX

    August 8, 2012
    On a good day for the market, the Nasdaq has climbed 0.1%, the S&P 500 has risen 0.2% and the Dow is up 0.3%. The healthcare ...
  8. Healthcare Sector's Biggest Movers: HCA Holdings and More

    August 6, 2012
    The market is currently up, with the Nasdaq climbing 1%, the S&P 500 rising 0.5% and the Dow up 0.6%. The healthcare sector ...
  9. FDA Nod for Perrigo Generic - Analyst Blog

    June 29, 2012
    Perrigo Co. (PRGO) recently announced that it had received US Food and Drug Administration (FDA) approval for its abbreviated ...
  10. 2011 In Review - Pharmaceuticals

    December 29, 2011
    2011 was a surprisingly healthy year for drug stocks.
  11. Medicis May Not Stay Independent

    November 10, 2011
    Medicis is well-run, but arguably too risky to stay independent.
  12. Irish Stocks Present Possible Value Play

    March 9, 2011
    Despite its fiscal woes, Ireland' tech story could ultimately become its saving grace.
Investing News
  1. 3 Dumb Ways to Borrow Money

    Money — everyone needs it, but not everyone has it. Many people who find themselves in a ...
  2. Infographic - The Lifecycle of a Bond

    Basic information on how Bonds work.
  3. What $200,000 Will Buy In The Atlanta Real Estate Market

    Atlanta housing prices are up from last year, but they're still lower than the national median. ...
  4. Bubble Bursting? Only For Biotech & Internet Stocks

    The recent sluggish performance of U.S. stocks is leading some market watchers to question ...
  5. What $300,000 Will Buy In The Riverside/San Bernardino Real Estate Market

    The median list price for the San Bernardino/Riverside, Calif. market is $292,800, up 24.6% ...
  6. What Is Worse Than Being At Risk?

    You may have heard the old adage: “What is worse than being lost? Not knowing you are lost.” ...
Trading Center